Getting Beyond the Flags: Quantitative assessment of immature granulocyte (IG) populations may improve the assessment of sepsis and inflammation.

Similar documents
WHITE PAPER IMMATURE GRANULOCYTE (IG) POPULATIONS MAY IMPROVE THE ASSESSMENT OF INFECTION AND SEPSIS. Getting beyond the flags.

Evaluation of the Diagnostic Performance of the Sysmex XT-2000i Automated Hematology Analyzer in the Detection of Immature Granulocytes

Precision and Accuracy of the Leukocyte Differential on the Sysmex XE-2100

5/1/2017 DISCUSSION POINTS. Clinical Utility of Immature Cell Indices Beyond the Routine CBC John E. Donnelly BSN, RN

Flow cytometry leukocyte differential : a critical appraisal

Full Blood Count analysis Is a 3 part-diff good enough? Dr Marion Münster, Sysmex South Africa

Customer Information Literature List White Blood Cells

10/30/2015. XN Case Studies: Every Picture Tells a Story

ADVANCED HAEMATOLOGY BATTLE OF THE BANDS. Dennis B. DeNicola, DVM, PhD, DACVP IDEXX Laboratories, Inc. Westbrook, Maine, USA BACKGROUND

Clinical Utility. Clinical Utility of the Automated IG-Count Xavier Troussard

Evidence-Based Hematological Solutions

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

INFECTION/ INFLAMMATION

Biochemical and Hematological Markers of Inflammation Accurately Predict Sepsis and its Severity in ICU Patients

CELL-DYN Strength in Technology, Proven Reliability. Optical WBC Technology. Patented M.A.P.S.S. Differential. Multiple Technologies

Performance evaluation of Celltac G: a new automated hematology analyzer

Sysmex Journal International Vol.9 No.2 (1999)

Lavender Top Management SUCCESS BEYOND FINANCES

Lavender Top Management SUCCESS BEYOND FINANCES. Mission/ Vision

Automated Hematology Analyzer. Differentiate with the XT-4000i

Abbott Cell-Dyn Reticulocyte Method Comparison and Reticulocyte Normal Reference Range Evaluation

A Look Into the Determination of Cell Morphology in Hematology in the 21 st Century. Ramon Simon-Lopez, MD Global Scientific Director Beckman Coulter

Evaluation of the Abbott CELL-DYN 4000 Hematology Analyzer

Customer Information Literature List Platelets

CELL-DYN 3700 Strength in Technology, Proven Reliability

XN series. Case interpretation. Gebruikersdag Vlaanderen- 6 oktober 2016

HumaCount 5D. Outperforming 5-part Hematology System. CoreLab DX. Hematology

Collect and label sample according to standard protocols. Gently invert tube 8-10 times immediately after draw. DO NOT SHAKE. Do not centrifuge.

XN-SERIES. XN Technology and Case Studies

XN-SERIES. Hematology Case Studies: Every Picture Tells a Story

Myelodysplasia/Myeloproliferative Neoplasms (MDS/MPN) Post-HCT Data

Leukocytosis. dr. Erdélyi, Dániel 2 nd Department of Paediatrics Semmelweis University

8/28/2015. ACP Toolbox SYSMEX CLINICAL SUPPORT TEAM SYSMEX CUSTOMER RESOURCE CENTER. Maggie Fischer BSN, RN, MS Carolyn Williams, BSN, RN, CRNI

The Value-Driven Laboratory. The Role of the Immature Platelet Fraction (IPF) in the Differential Diagnosis of Thrombocytopenia

Evaluation of a Method for Counting Absolute Numbers of Cells with a Flow Cytometer

2007 Workshop of Society for Hematopathology & European Association for Hematopathology Indianapolis, IN, USA Case # 228

Hematopathology Case Study

Flow Cytometric White Blood Cell Differential Using CytoDiff is Excellent for Counting Blasts

The Value-Driven Laboratory. The Role of the Immature Platelet Fraction (IPF) in the Differential Diagnosis of Thrombocytopenia

Extramedullary precursor T-lymphoblastic transformation of CML at presentation

Literature List Body Fluids

Blood DLC, Retic count, PCV, Hb and ESR. Dr. Tamara Alqudah

Case Presentation No. 075

Sysmex Journal International Vol.26 No.1 (2016)

Interpreting Hematology Scatter-Plots; One Cancer Center s Keys to Seeing the BIG Picture

PointCare NOW TM Technical Note

A HemoCue Novel Technology Product for 5-Part Differentiation of Leukocytes Point-of-Care

Sue Jung Kim, MD, MS; Yoonjung Kim, MD; Saeam Shin, MD; Jaewoo Song, MD, MS; Jong Rak Choi, MD, PhD

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Literature List White Blood Cells

Leukocytosis - Some Learning Points

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

number Done by Corrected by Doctor موسى العبادي

Hematopathology Case Study

Fluorescence immunoassay Point of care test Wide range PCT. whole blood. plasma. serum

BACKGROUND. Absolute neutrophil counts (ANCs) and absolute phagocyte counts

Identification and Enumeration of Nucleated Red Blood Cells in Peripheral Blood

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

3. Blood Cell Histograms:

We noted a problem with the use of the hematology

Evaluation of Coulter S-Plus Three-part Differential in Population with a High Prevalence of Abnormalities

Guide to the 1-3 Minute Blood Film Microscopic Review: Why and How?

HSCT MANAGEMENT WHITE PAPER. Managing stem cell apheresis effectively

Evaluation of Early Post-transplant Leukocyte Recovery Using the Undiluted Erythrocyte Lysing Technique

Changes of hematological references depends on storage period and temperature conditions in rats and dogs

2008 CAP TODAY Q & A

IMMATURE PLATELETS CLINICAL USE

of s and s Disclosure

Changes in Automated Complete Blood Cell Count and Differential Leukocyte Count Results Induced by Storage of Blood at Room Temperature

LYDIA NELSON, M.S., MT(ASCP), SH, SAMUEL CHARACHE, M.D., SANDRA WINGRELD, MT(ASCP), AND EDWARD KEYSER, MT(ASCP)

NUMERATOR: Patients who had baseline cytogenetic testing performed on bone marrow

JMSCR Vol 3 Issue 10 Page October 2015

Blutbild 2012: Automatisiert oder manuell? Georg Stüssi Servizio di Ematologia Istituto Oncologico della Svizzera Italiana

Morphology Case Study. Presented by Niamh O Donnell, BSc, MSc. Medical Scientist Haematology Laboratory Cork University Hospital

LEANING Away Waste and Improving Patient Care with Advances in Hematology

Cbc with differential

CAROL BRIGGS, DONNA GRANT, SAMUEL J. MACHIN INTRODUCTION. Department of Haematology, University College London Hospital, London, United Kingdom

Critical Review Form Meta-analysis

Myelodysplastic scoring system with flow cytometry. G Detry B Husson

Combining. and New Diagnostic. to Help Clinicians Achieve. Patient Outcomes at. per Healthcare Encounter

FLOW CYTOMETRIC ANALYSIS OF NORMAL BONE MARROW

Avoiding Early Cancer Claims. Presentation #4. Hank George, FALU

HISTOLOGY VIRTUAL LABORATORY BLOOD AND LYMPHATICS SYSTEM

Do Your Flow Cytometric LDTs. Validation Guidelines? Fiona E. Craig, MD University of Pittsburgh School of Medicine

Performance Evaluation of NS-hema21t Automated Hematology Analyzer and Comparison of the Hematological Parameters with Sysmex XT1800i

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

How To Do A Manual White Blood Cell Count Up After Chemotherapy

It s Easier Than you Think How to Implement the Advanced Clinical Parameters

The Evolving Role of Reticulated Platelets

Welcome. Welcome. Emerging Technologies in Flow Cytometry

Collected: , PM Sent: , PM Received: , PM Preliminary: , PM. Notification Status: COMPREHENSIVE DIAGNOSIS

Hematology 101. Cindy Rogers, MT(ASCP) Diagnostics System Specialist

Scoring System for Detecting Spurious Hemolysis in Anticoagulated Blood Specimens

Preechaya Wongkrajang, M.D., Chaicharoen Tantanate, M.D. ABSTRACT

PanLeucogating Akin Abayomi

EDUCATIONAL COMMENTARY MORPHOLOGIC ABNORMALITIES IN LEUKOCYTES

Transcription:

Getting Beyond the Flags: Quantitative assessment of immature granulocyte (IG) populations may improve the assessment of sepsis and inflammation. Sysmex America White Paper One Nelson C. White Parkway, Mundelein, IL 60060 Tel. 1-847-996-4500 1-800-3SYSMEX (1-800-379-7639) www.sysmex.com

Getting Beyond the Flags: Quantitative assessment of immature granulocyte (IG) populations may improve the assessment of sepsis and inflammation. Introduction In reviewing hematological laboratory results, the presence of a left shift has been a diagnostic tool that has been utilized by physicians for decades. Clinically, the presence of a left shift or immature granulocytes in the peripheral circulation can be indicative of a number of disorders (Table 1). The problem is that the term left shift can have a variety of definitions. Does it mean the presence of band neutrophils, or the presence of bands, metamylelocytes, myleocytes and promyelocytes. When the left shift is observed and enumerated using a manual 100-cell differential, the results can be imprecise due to so few cells being counted, particularly in leukopenic samples. Furthermore, results are not reproducible between operators because of differences in morphology interpretation. In recent years, the ability to count the presence of immature granulocytes (metamylelocytes, myleocytes and promyelocytes) by an automated cell counter has come to fruition. The days when a hematology analyzer would produce a suspect flag indicating the possible presence of immature granulocytes and the need for a manual differential, has come to an end. The Sysmex XE-Series and XT-Series analyzers are equipped with a proprietary software algorithm that counts over 32,000 cells and can generate accurate and reproducible quantitative immature granulocyte counts. The instruments are able to identify and provide an absolute count and percent of the immature granulocyte population comprised of metamyelocytes, myelocytes and promyelocytes. These three cell types are separated from the neutrophil population based on their increased fluorescence emission due to higher levels of DNA and RNA. The measurement is made in less than 25 seconds and is reported automatically with the other CBC results. Table 1. Disorders associated with immature granulocytes in the peripheral circulation. Infection, esp. bacterial Severe inflammatory disease Myelodysplastic syndromes Myeloproliferative disease Chronic Myeloid Leukemia (CML) Myelofibrosis Metastatic bone marrow malignancy Trauma Acute organ transplant rejection

(A) (B) (C) Patient SSC-Height 0 200 400 600 800 1000 Gran total WBC Mono Debris Baso Lymph CD45-PerCP CD45-PerCP Eo Neut CD16-FITC CD11b-PE IG stage 2 Mature Neut IG stage 1 CD16-FITC Normal SSC-Height 0 200 400 600 800 1000 Gran total WBC Debris Baso Mono Lymph CD45-PerCP Eo Neut IG stage 2 Mature Neut IG stage 1 CD45-PerCP CD16-FITC CD16-FITC CD11b-PE Figure 1. Flow cytometric analysis of a patient sample containing IG and a sample from a normal, healthy volunteer after staining with CD45-PerCP, CD16-FITC, and CD11b-PE. In the first step, granulocytes (IG + neutrophils + eosinophils) were identified (A). In the second step, neutrophils and IG were seperated from eosinophils (B). In the third step, (C), IG stage 1 (CD16 - /CD11b - ) and stage 2 (CD16 - /CD11b + ) were identified as well as mature neutrophils (CD16 + /CD11b + ). No IG were identified in any samples from normal, healthy adult individuals. Correlation studies: gaining agreement Early studies using flow cytometry (1) showed that it is possible to differentiate immature granulocytes from mature forms and that improved accuracy and reproducibility was possible because 10,000 cells could be interrogated versus 100 manually. These studies used flow cytometry and monoclonal antibody labeling to identify immature granulocytes (IGs). CD45, the leukocyte common antigen, was used to detect cells of hematopoietic origin. Promyelocytes and myelocytes were stained with CD16 - /CD11b - ; metamyelocytes with CD16 - / CD11b + ; and mature granulocytes with CD16 + /CD11b +. This allowed for the measurement of multiple parameters such as light scatter and fluorescent labels rather than morphological characteristics only. Figure 1 shows the flow cytometry results of a patient with immature granulocytes and a normal, healthy volunteer. The authors suggested that this flow cytometry method might be suitable for following cases of infectious disease.

The ability to automate the abnormal white cell differential with quantitative results was reported by Briggs et al (2) in 2003. This team compared manual light microscopy, flow cytometry and an upgraded software for identifying and counting IGs: XE-IG Master (Sysmex America, Inc.). The new software allowed the Sysmex XE and XT- Series hematology analyzers to measure cellular light scatter and fluorescence emission in the leukocyte differential channel. An erythrocyte lysing reagent also acts upon white cells to prepare them for staining. A proprietary nucleic acid dye stains leukocytes, and a laser diode measures sidelight scatter and side-fluorescence. IGs are distinguished by their high fluorescence intensity and are reported as a % of the leukocyte population and absolute count. Figure 2 shows the correlation between Flow Cytometry (IG%) and XE-IG Master (IG%) determinations, and Figure 3 shows the correlation between the manual 400-cell differential and the XE-IG Master (IG%). Briggs et al also reported on the reproducibility of the XE-2100 instrument using the new Master software using 10 repeat analyses on 8 patient samples. For IG%, the mean CV was 7.02% and for absolute count, the mean CV was 6.93%. Samples were stable for up to 48 hours either at room temperature or refrigerated. Fernandes and Hamaguchi (3) reported excellent correlation between flow cytometric counts [Fujimoto method (1)] and the XE-2100 IG count. Correlation coefficients of 0.93 and 0.95 were determined for absolute count and % respectively. Correlation coefficients between the XE-2100 and manual counts were.82 and.80 for absolute and % determinations. Again, samples were stable at room temperature and refrigerated temperatures. Figure 2. The correlation of the percentage of immature granulocytes (IG%) determined by the flow cytometry reference method with the IG% determined by the XE-IG Master Method. Flow cytometric IG counting based on a 3-color method using fluorescein isothiocyanate (FITC)- CD16, FITC-CD11b, and peridinin chlorophyll protein-cd45 was used as the reference method. Figure 3. The correlation of the percentage of immature granulocytes (IG%) determined by the manual count reference method with the IG% determined by the XE- IG Master method. The manual IG differential based on a 400-cell leukocyte count was used as the reference method. 15 Ref: Flow Cytometry 15 Ref: Manual Differential 12 12 XE-IG Master (IG%) 9 6 3 y = 0.91 x + 0.10 r = 0.96 n = 54 XE-IG Master (IG%) 9 6 3 y = 0.81 x + 1.27 r = 0.78 n = 59 0 0 3 6 9 12 15 Flow Cytometry (IG%) 0 0 3 6 9 12 15 Manual Differential (IG%)

Acute Phase Reactants Table 2 lists positive acute phase reactants (APRs) that may be helpful in the assessment of inflammation and infection. Briggs et al (2) looked at the following APRs in their 2003 study: CRP, ESR, CD64, IL-6 and IG counts as determined on the XE-2100 analyzer. Samples with high IG and normal neutrophil counts were studied (n=43). Of these, 15 patients had an infectious disease and 14 had postoperative bleeding. The mean IG count for these 43 samples was 3.9% (range 2.0% 11.0%) and the mean neutrophil count was 5.21 x 10 9 /L (range 2.01-7.49 x 10 9 /L). The values for CRP, ESR, PMN cell index and IL-6 were all high, but to varying degrees. Those with a high IG count showed good correlation with CRP and the ESR (84% and 95% respectively), despite neutrophil counts in the normal range. (Figure 4) Table 2. Positive Acute Phase Reactants (3, 7) WBC (high, low or normal) Immature granulocytes (peripheral blood) C-Reactive Protein Interleukin I (IL-1) Interleukin 6 (IL-6) Tumor Necrosis Factor (TNF) CD-64 ESR ( sed rate ) Ceruloplasmin Components of complement cascade Cerum amyloid A Fibrinogen Alpha-1 antitrypsin Haptoglobin Ferritin Figure 4. Positive sample rates in samples with high immature granulocyte counts (2.0% or higher) and normal neutrophil levels (2.0-7.5 x 10 9 /L). CPR indicates C-reactive protein; ESR, erythrocyte sedimentation rate; IL-6, interleukin 6. Automated Immature Granulocyte Counts on the Sysmex XE-2100 CRP 84.0% 16.0% ESR CD64 95.0% 5.0% 80.3% 19.7% Positive Negative IL-6 57.8% 42.2% 0% 20% 40% 60% 80% 100% Sample Rate CRP ESR CD64 IL-6 Positive Number of Samples Criteria Positive Negative Total 5.0 mg/dl 20 mm/hr 3.0 5.8 pg/ml 42 (84.0%) 19 (95.0%) 61 (80.3%) 37 (57.8%) 8 (16.0%) 1 (5.0%) 15 (19.7%) 27 (42.2%) 50 20 76 64

In another study (4), IG% as a predictor of infection or sepsis was assessed using blood samples from 102 infected individuals and 69 non-infected individuals. Analyzed on the Sysmex XE-2100 instrument, IG% was significantly higher in infected versus noninfected patients (Table 3) as well as patients with positive versus negative blood culture results (Table 4). In 11 of 12 patients with IG% values greater than 3%, the specificity of IG% was greater than 90%. Similar to Brigg s findings, IG% correlated better than the absolute white cell count and was comparable to the absolute neutrophil count, although neither parameter had the sensitivity to be used as a sole screening tool. Rather, it was suggested that the value of an increased IG% of greater than 3% could be useful as part of an algorithm-driven panel of tests. Another study, this time in pediatric patients (5), compared CRP, IG ratio (IG%/total white cell count) and IT ratios (IG%/ total neutrophil count) to see if they could be used as an early indicator of sepsis. In this study, sepsis [Systemic Inflammatory Response (SIRS)] was diagnosed when a patient presented with two or more of the symptoms shown in Table 5. The IT ratio is a new way of looking at IG% and the authors suggest that it may be more specific in diagnosing sepsis since it considers not only the absolute number of immature granulocytes but compares it to the total neutrophil count. In this way, the parameter may be an indicator of the bone marrow activation seen in sepsis. A total of 58 patients were evaluated: 31 with positive blood culture results; 7 with negative blood cultures, but clinicallydiagnosed sepsis; 20 negative for sepsis. The patients considered septic had elevated IG% and IT%, the latter particularly raised and in one case elevated to 37.5%. Negative controls did not have ratios higher than 3%. Another group of patients studied were those with negative blood cultures but clinically diagnosed with sepsis, perhaps as a result of antibiotic treatment. All seven of these patients had elevated IG and IT ratios compared to the negative controls. To determine a viable cut-off point, the authors decided that eliminating false negatives would be clinically more prudent than eliminating false positives and determined the cut-offs to be 0.35 for IG and 0.65 for IT, which would provide a sensitivity of greater than 70% at the best possible specificity. Using the cut-off values of 0.35 (IG) and 0.65 (IT) values, sensitivities were 74% (Table 5). The IT ratio appeared to be somewhat more sensitive and had better positive and negative predictive values than the IG ratio, perhaps because it is calculated using the neutrophil count rather than the leukocyte count, providing better sensitivity in neutropenic samples. By following patients that had 3-days pre-diagnosis, day of diagnosis and 3 days post-diagnosis data available, the IT ratio showed a rise higher than that of the IG ratio up to 3 days prior to a positiveblood culture. This study of IG and IT ratios also looked at CRP levels in those patients for whom it was available: 21 of 38 septic patients and 17 of 20 in the negative control group. Using a threshold of greater than 11mg/L for CRP, 68% of the septic patients had an increased CRP, although because of the few subjects, this number should be interpreted conservatively. Nonetheless, it was determined that the sensitivity of CRP, in this study at least, was lower than for IT and IG ratios at 71%. The specificity of CRP was also low at 35% compared to the IT ratio of 50% in this pediatric population.

Table 3. Comparison of WBC Count and Percentage of Immature Granulocytes Measurements as Predictors of Infection. Infected (n = 102) Not Infected (n = 69) P Mean ± SD WBC count, /µl (x 10 9 /L) Mean ± SD immature granulocyte percentage Proportion 1% 10,800 ± 7,000 (10.8 ± 7.0) 1.6 ± 2.8 50 (49.0%) 8,400 ± 5,000 (8.4 ± 5.0) 0.7 ± 0.8 14 (20%) <.01 <.001 <.0001 Table 4. Comparison of WBC Count and Percentage of Immature Granulocytes Measurements as Predictors of Sepsis. Culture Positive (n = 91) Culture Negative (n = 51) P Mean ± SD WBC count, /µl (x 10 9 /L) Mean ± SD immature granulocyte percentage Proportion 1% Proportion > 3% 10,300 ± 7,300 (10.3 ± 7.3) 2.0 ± 3.6 39 (43%) 10,200 ± 5,500 (10.2 ± 5.5) 0.7 ± 0.8 12 (24%) NS.005.02 11 (12%) 1 (2%).04 NS, not significant. Table 5. Positive predictive values, sensitivities and specifies of both the IG and IT ratios at their established thresholds. sensitivity specificity positive predictive value negative predictive value IT ratio > 0.65 74% IG ratio > 0.35 74% 50% 35% 74% 68% 50% 41% Summary Diagnosis is complex in sepsis due to a broad range of non-specific symptoms and an equally broad range of laboratory tests that may help the diagnosis. Microbiologic testing in the form of blood cultures may border on being a gold standard, but takes up to four days before results are known. The test can also provide false positive and false negative results, frequently due to faulty blood collection techniques. Therefore, the search for quick and economical alternatives to this and the many tests cited here continues. Now that the laboratory is able to report the immature granulocyte population with a high degree of accuracy and precision, the clinical utility of the WBC count and differential can significantly increase. Physicians will have additional diagnostic parameters to consider when assessing inflammation and acute infection so that timely intervention with appropriate therapeutics can be made. Hematologic and biochemical tests can contribute to a diagnosis as noted previously in the Briggs et al study, and the fact that the XE-2100 instrument is able to provide highly precise and accurate immature granulocyte information keeps investigators looking at this parameter. This comprehensive reporting may help improve laboratory productivity by eliminating manual reviews on systems that rely on flags to indicate the need for a manual examination for immature granulocytes, some of which will be false positives. As investigators compile information on IG count and IG% and study these parameters along with other acute phase reactants, it may be possible to develop a diagnostic algorithm for laboratory results to aid in the identification of acute inflammation and sepsis.

References 1. Fujimoto H, Sakata T, Hamaguchi Y, et al. 2000. Flow Cytometric Method for Enumeration and Classification of Reactive Immature Granulocyte Populations. Cytometry (Communications in Clinical Cytometry) 42:371-378. 2. Briggs C, Kunka S, Fujimoto H, et al. 2003. Evaluation of Immature Granulocyte Counts by the XE-IG Master: Upgraded Software for the XE-2100 Automated Hematology Analyzer. Laboratory Hematology. 9:117-124. 3. Fernandes B, Hamaguchi Y. 2007. Automated Enumeration of Immature Granulocytes. Hematopathology. American Journal of Pathology. 128:454-463. 4. Ali Ansari-ari M, Kickler TS, Borowitz MJ. 2003. Immature Granulocyte Measurement using the Sysmex XE-2100. American Journal of Clinical Pathology 120:795-799. 5. Iddles C, Taylor J, Cole R, Hill FGH. 2007 Evaluation of the Immature Granulocyte Count in the Diagnosis of Sepsis Using the Sysmex XE-2100. Sysmex Journal Inteernatinal.17: Suppl. 1/No. 1. 6. Barnes PW, McFadden S. L., Machin SJ, E. Simson E.4. 2005 The International Consensus Group for Hematology. Review: Suggested Criteria for Action Following Automated CBC and WBC Differential Analysis. Laboratory Hematology 11:83-90. 7. http://www.uptodate.com/patients/content/topic.do?topickey=~22ip2ecyo1z07yp Disclaimer The uses or clinical applications described in these publications have not been approved or cleared by the FDA. It is the clinician s responsibility to validate any off-label applications for use in routine clinical practice. Notice of Intended Use: The Immature Granulocyte (IG) parameter on the Sysmex XE-2100 is intended for in vitro diagnostic use to classify and count immature granulocyte cells in EDTA anticoagulated blood. 2012 Sysmex America, Inc. Document Number MKT-10-1066 4/2012 One Nelson C. White Parkway, Mundelein, IL 60060 Tel. 1-847-996-4500 1-800-3SYSMEX (1-800-379-7639) www.sysmex.com